Adamis Pharmaceuticals | ADMP - Capitale Ordinario



Capitale Ordinario Cambiamento Data
Adma Biologics USD 237.88M 457K 2025-12
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Brainstorm Cell Therapeutics USD 11.03M 913K 2025-09
Cara Therapeutics USD 2K 3K 2025-03
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.08B 49.43M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Merck USD 2.49B 15.79M 2025-09
Pfizer USD 5.69B 1000K 2025-09
RedHill Biopharma USD 33.3B 20.4B 2025-06